{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,10]],"date-time":"2026-10-10T02:16:14Z","timestamp":1791598574850,"version":"4.3.4"},"reference-count":91,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2020,10,1]],"date-time":"2020-10-01T00:00:00Z","timestamp":1601510400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,10,1]],"date-time":"2020-10-01T00:00:00Z","timestamp":1601510400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Ocular Surface"],"published-print":{"date-parts":[[2020,10]]},"DOI":"10.1016\/j.jtos.2020.09.001","type":"journal-article","created":{"date-parts":[[2020,9,12]],"date-time":"2020-09-12T00:03:03Z","timestamp":1599868983000},"page":"871-892","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":45,"title":["Latest evidences on meibomian gland dysfunction diagnosis and management"],"prefix":"10.1016","volume":"18","author":[{"given":"Edoardo","family":"Villani","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6646-8907","authenticated-orcid":false,"given":"Luca","family":"Marelli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrea","family":"Dellavalle","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Massimiliano","family":"Serafino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paolo","family":"Nucci","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jtos.2020.09.001_bib1","doi-asserted-by":"crossref","first-page":"1922","DOI":"10.1167\/iovs.10-6997a","article-title":"The international workshop on meibomian gland dysfunction: executive summary","volume":"52","author":"Nichols","year":"2011","journal-title":"Investig Ophthalmol Vis Sci"},{"key":"10.1016\/j.jtos.2020.09.001_bib2","doi-asserted-by":"crossref","first-page":"1930","DOI":"10.1167\/iovs.10-6997b","article-title":"The international workshop on meibomian gland dysfunction: report of the definition and classification subcommittee","volume":"52","author":"Daniel Nelson","year":"2011","journal-title":"Investig Ophthalmol Vis Sci"},{"key":"10.1016\/j.jtos.2020.09.001_bib3","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1136\/bjophthalmol-2015-307415","article-title":"Revisiting the vicious circle of dry eye disease\u00a0: a focus on the pathophysiology of meibomian gland dysfunction","author":"Baudouin","year":"2016","journal-title":"Br J Ophthalmol"},{"key":"10.1016\/j.jtos.2020.09.001_bib4","doi-asserted-by":"crossref","first-page":"2006","DOI":"10.1167\/iovs.10-6997f","article-title":"The international workshop on meibomian gland dysfunction: report of the diagnosis subcommittee","volume":"52","author":"Tomlinson","year":"2011","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"10.1016\/j.jtos.2020.09.001_bib5","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1038\/s41433-019-0351-0","article-title":"Imaging of meibomian glands: from bench to bedside and back","volume":"33","author":"Villani","year":"2019","journal-title":"Eye"},{"issue":"Suppl 2","key":"10.1016\/j.jtos.2020.09.001_bib6","doi-asserted-by":"crossref","first-page":"S141","DOI":"10.1097\/ICL.0000000000000650","article-title":"Imaging biomarkers for dry eye disease","volume":"46","author":"Villani","year":"2020","journal-title":"Eye Contact Lens"},{"key":"10.1016\/j.jtos.2020.09.001_bib7","doi-asserted-by":"crossref","first-page":"DES48","DOI":"10.1167\/iovs.17-23631","article-title":"Meibography: a Japanese perspective","volume":"59","author":"Arita","year":"2018","journal-title":"Investig Ophthalmol Vis Sci"},{"key":"10.1016\/j.jtos.2020.09.001_bib8","doi-asserted-by":"crossref","first-page":"2050","DOI":"10.1167\/iovs.10-6997g","article-title":"The international workshop on meibomian gland dysfunction: report of the subcommittee on management and treatment of meibomian gland dysfunction","volume":"52","author":"Geerling","year":"2011","journal-title":"Investig Ophthalmol Vis Sci"},{"key":"10.1016\/j.jtos.2020.09.001_bib9","doi-asserted-by":"crossref","first-page":"529","DOI":"10.7326\/0003-4819-155-8-201110180-00009","article-title":"QUADAS-2: a revised tool for the quality assessment of diagnostic accuracy studies","volume":"155","author":"Whiting","year":"2011","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.jtos.2020.09.001_bib10","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1186\/1471-2288-3-25","article-title":"The development of QUADAS: a tool for the quality assessment of studies of diagnostic accuracy included in systematic reviews","volume":"3","author":"Whiting","year":"2003","journal-title":"BMC Med Res Methodol"},{"key":"10.1016\/j.jtos.2020.09.001_bib11","first-page":"1193","article-title":"The periodic health examination. Canadian Task Force on the periodic health examination","volume":"121","year":"1979","journal-title":"Can Med Assoc J"},{"key":"10.1016\/j.jtos.2020.09.001_bib12","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1016\/j.sjopt.2012.08.007","article-title":"Meibography: a review of techniques and technologies","volume":"26","author":"Wise","year":"2012","journal-title":"Saudi J Ophthalmol"},{"key":"10.1016\/j.jtos.2020.09.001_bib13","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1007\/s10384-006-0397-y","article-title":"A newly developed video-meibography system featuring a newly designed probe","volume":"51","author":"Yokoi","year":"2007","journal-title":"Jpn J Ophthalmol"},{"key":"10.1016\/j.jtos.2020.09.001_bib14","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0165558","article-title":"A simple novel technique of infrared meibography by means of spectral-domain optical coherence tomography: a cross-sectional clinical study","volume":"11","author":"Napoli","year":"2016","journal-title":"PloS One"},{"key":"10.1016\/j.jtos.2020.09.001_bib15","doi-asserted-by":"crossref","first-page":"2058","DOI":"10.1016\/j.ophtha.2009.04.037","article-title":"Proposed diagnostic criteria for obstructive meibomian gland dysfunction","volume":"116","author":"Arita","year":"2009","journal-title":"Ophthalmology"},{"key":"10.1016\/j.jtos.2020.09.001_bib16","article-title":"Noncontact infrared meibography to document age-related changes of the meibomian glands in a normal population","volume":"911\u20135","author":"Arita","year":"2007","journal-title":"Ophthalmology"},{"key":"10.1016\/j.jtos.2020.09.001_bib17","doi-asserted-by":"crossref","first-page":"16\u201025","DOI":"10.1016\/j.ajo.2018.12.006","article-title":"Meibomian gland morphology is a sensitive early indicator of meibomian gland dysfunction","volume":"200","author":"Adil","year":"2019","journal-title":"Am J Ophthalmol"},{"key":"10.1016\/j.jtos.2020.09.001_bib18","article-title":"Diagnostic test efficacy of meibomian gland morphology and function","volume":"1\u20138","author":"Xiao","year":"2019","journal-title":"Sci Rep"},{"key":"10.1016\/j.jtos.2020.09.001_bib19","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1016\/j.jtos.2019.04.003","article-title":"The Ocular Surface Grading and baseline characteristics of meibomian glands in meibography images and their clinical associations in the Dry Eye Assessment and Management ( DREAM ) study","volume":"17","author":"Daniel","year":"2019","journal-title":"Ocul Surf"},{"key":"10.1016\/j.jtos.2020.09.001_bib20","doi-asserted-by":"crossref","first-page":"788","DOI":"10.1097\/OPX.0b013e318253de93","article-title":"Infrared imaging of meibomian gland structure using a novel keratograph","volume":"89","author":"Srinivasan","year":"2012","journal-title":"Optom Vis Sci"},{"key":"10.1016\/j.jtos.2020.09.001_bib21","doi-asserted-by":"crossref","first-page":"918","DOI":"10.1001\/archopht.1959.00940090920007","article-title":"Cystic degeneration of the meibomian glands","volume":"61","author":"Straatsma","year":"1959","journal-title":"AMA Arch Ophthalmol"},{"key":"10.1016\/j.jtos.2020.09.001_bib22","doi-asserted-by":"crossref","first-page":"925","DOI":"10.1016\/j.ophtha.2014.12.018","article-title":"Increased tear fluid production as a compensatory response to meibomian gland loss A multicenter cross-sectional study","volume":"122","author":"Arita","year":"2014","journal-title":"Ophthalmology"},{"key":"10.1016\/j.jtos.2020.09.001_bib23","first-page":"691","article-title":"n-3 fatty acid supplementation and dry eye disease","volume":"379","author":"Maguire","year":"2018","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jtos.2020.09.001_bib24","doi-asserted-by":"crossref","first-page":"160\u2010167","DOI":"10.1016\/j.ajo.2019.09.005","article-title":"Functional and morphological evaluation of meibomian glands in the assessment of meibomian gland dysfunction subtype and severity","volume":"209","author":"Xiao","year":"2020","journal-title":"Am J Ophthalmol"},{"key":"10.1016\/j.jtos.2020.09.001_bib25","first-page":"2","article-title":"Vivo 3D meibography of the HumanEyelid using real time imaging fourier-domain OCT","volume":"8","author":"Hwang","year":"2013","journal-title":"PloS One"},{"key":"10.1016\/j.jtos.2020.09.001_bib26","doi-asserted-by":"crossref","first-page":"1193","DOI":"10.1097\/ICO.0000000000000563","article-title":"Evaluation of optical coherence tomography meibography in patients with obstructive meibomian","volume":"34","author":"Liang","year":"2015","journal-title":"Cornea"},{"key":"10.1016\/j.jtos.2020.09.001_bib27","first-page":"2457","article-title":"The Application of in vivo laser scanning confocal microscopy as a tool of conjunctival in vivo cytology in the diagnosis of dry eye ocular surface disease","author":"Kojima","year":"2010","journal-title":"Mol Vis"},{"key":"10.1016\/j.jtos.2020.09.001_bib28","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1001\/archopht.120.3.330","article-title":"Goblet cell numbers and epithelial proliferation in the conjunctiva of patients with dry eye syndrome treated with cyclosporine","volume":"120","author":"Kunert","year":"2019","journal-title":"Arch Ophthalmol"},{"key":"10.1016\/j.jtos.2020.09.001_bib29","doi-asserted-by":"crossref","first-page":"9116","DOI":"10.1167\/iovs.11-7988","article-title":"Ocular surface epithelial thickness evaluation with spectral-domain optical coherence tomography","volume":"52","author":"Francoz","year":"2011","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"10.1016\/j.jtos.2020.09.001_bib30","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1016\/j.jtos.2016.10.001","article-title":"Examination of gland dropout detected on infrared meibography by using optical coherence tomography meibography","volume":"15","author":"Yoo","year":"2017","journal-title":"Ocul Surf"},{"key":"10.1016\/j.jtos.2020.09.001_bib31","doi-asserted-by":"crossref","first-page":"1938","DOI":"10.1167\/iovs.10-6997c","article-title":"The international workshop on meibomian gland dysfunction: report of the subcommittee on anatomy, physiology, and pathophysiology of the meibomian gland","volume":"52","author":"Knop","year":"2011","journal-title":"Investig Ophthalmol Vis Sci"},{"key":"10.1016\/j.jtos.2020.09.001_bib32","doi-asserted-by":"crossref","first-page":"6111","DOI":"10.1167\/iovs.18-25571","article-title":"Clinically relevant immune-cellular metrics of inflammation in meibomian gland dysfunction","volume":"59","author":"Qazi","year":"2018","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"10.1016\/j.jtos.2020.09.001_bib33","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1016\/j.ophtha.2009.12.029","article-title":"The efficacy, sensitivity, and specificity of in vivo laser confocal microscopy in the diagnosis of meibomian gland dysfunction","volume":"117","author":"Ibrahim","year":"2010","journal-title":"Ophthalmology"},{"key":"10.1016\/j.jtos.2020.09.001_bib34","first-page":"933\u2010939","article-title":"In vivo confocal microscopy of meibomian glands in Sj\u00f6gren's syndrome","volume":"52","author":"Villani","year":"2011","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"10.1016\/j.jtos.2020.09.001_bib35","doi-asserted-by":"crossref","first-page":"754","DOI":"10.1038\/s41433-018-0307-9","article-title":"In vivo confocal microscopy classification in the diagnosis of meibomian gland dysfunction","volume":"33","author":"Randon","year":"2019","journal-title":"Eye"},{"key":"10.1016\/j.jtos.2020.09.001_bib36","doi-asserted-by":"crossref","first-page":"4249","DOI":"10.1167\/iovs.18-24497","article-title":"Wide-field in vivo confocal microscopy of meibomian gland acini and rete ridges in the eyelid margin","volume":"59","author":"Zhou","year":"2018","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"10.1016\/j.jtos.2020.09.001_bib37","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1167\/tvst.8.6.37","article-title":"A deep learning approach for meibomian gland atrophy evaluation in meibography images","volume":"8","author":"Wang","year":"2019","journal-title":"Transl Vis Sci Technol"},{"key":"10.1016\/j.jtos.2020.09.001_bib38","doi-asserted-by":"crossref","first-page":"720\u2010725","DOI":"10.1097\/ICO.0000000000002279","article-title":"Deep neural network-based method for detecting obstructive meibomian gland dysfunction with in vivo laser confocal microscopy","volume":"39","author":"Maruoka","year":"2020","journal-title":"Cornea"},{"key":"10.1016\/j.jtos.2020.09.001_bib39","doi-asserted-by":"crossref","first-page":"7272","DOI":"10.1167\/iovs.14-15512","article-title":"Antimicrobial role of human meibomian lipids at the ocular surface","volume":"55","author":"Mudgil","year":"2014","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"10.1016\/j.jtos.2020.09.001_bib40","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1016\/j.jtos.2016.12.003","article-title":"Bacteriological profile of ocular surface flora in meibomian gland dysfunction","volume":"15","author":"Zhang","year":"2017","journal-title":"Ocul Surf"},{"key":"10.1016\/j.jtos.2020.09.001_bib41","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1097\/ICO.0b013e318254205f","article-title":"Topical azithromycin and oral doxycycline therapy of meibomian gland dysfunction","volume":"32","author":"Foulks","year":"2013","journal-title":"Cornea"},{"key":"10.1016\/j.jtos.2020.09.001_bib42","doi-asserted-by":"crossref","first-page":"1145","DOI":"10.1097\/ICO.0b013e318207fc42","article-title":"Oral azithromycin for treatment of posterior blepharitis","volume":"30","author":"Igami","year":"2011","journal-title":"Cornea"},{"key":"10.1016\/j.jtos.2020.09.001_bib43","doi-asserted-by":"crossref","first-page":"957","DOI":"10.1007\/s00417-005-0212-3","article-title":"Tear fluid levels of MMP-8 are elevated in ocular rosacea - treatment effect of oral doxycycline","volume":"244","author":"M\u00e4\u00e4tt\u00e4","year":"2006","journal-title":"Graefe\u2019s Arch Clin Exp Ophthalmol"},{"key":"10.1016\/j.jtos.2020.09.001_bib44","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1016\/j.clae.2015.08.002","article-title":"On the prescribing of oral doxycycline or minocycline by UK optometrists as part of management of chronic Meibomian Gland Dysfunction (MGD)","volume":"39","author":"Doughty","year":"2016","journal-title":"Contact Lens Anterior Eye"},{"key":"10.1016\/j.jtos.2020.09.001_bib45","first-page":"2970","article-title":"The role of tetracycline in chronic blepharitis: inhibition of lipase production in staphylococci","volume":"32","author":"Dougherty","year":"1991","journal-title":"Investig Ophthalmol Vis Sci"},{"key":"10.1016\/j.jtos.2020.09.001_bib46","doi-asserted-by":"crossref","first-page":"614","DOI":"10.1016\/j.phrs.2011.06.013","article-title":"The non-antibiotic properties of tetracyclines: clinical potential in ophthalmic disease","volume":"64","author":"Federici","year":"2011","journal-title":"Pharmacol Res"},{"key":"10.1016\/j.jtos.2020.09.001_bib47","doi-asserted-by":"crossref","first-page":"949","DOI":"10.1016\/j.ajo.2012.06.009","article-title":"Minocycline controls clinical outcomes and inflammatory cytokines in moderate and severe meibomian gland dysfunction","volume":"154","author":"Lee","year":"2012","journal-title":"Am J Ophthalmol"},{"key":"10.1016\/j.jtos.2020.09.001_bib48","first-page":"1016\u20101019","article-title":"Comparison of therapeutic effects of topical azithromycin solution and systemic doxycycline on posterior blepharitis","volume":"9","author":"Zandian","year":"2016","journal-title":"Int J Ophthalmol"},{"key":"10.1016\/j.jtos.2020.09.001_bib49","doi-asserted-by":"crossref","first-page":"1400","DOI":"10.1345\/aph.1D634","article-title":"The effect of clarithromycin on inflammatory markers in chronic obstructive pulmonary disease: preliminary data","volume":"38","author":"Basyigit","year":"2004","journal-title":"Ann Pharmacother"},{"key":"10.1016\/j.jtos.2020.09.001_bib50","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1016\/j.lab.2004.03.012","article-title":"Azithromycin inhibits interleukin-6 but not fibrinogen production in hepatocytes infected with cytomegalovirus and Chlamydia pneumoniae","volume":"144","author":"Jjm","year":"2004","journal-title":"J Lab Clin Med"},{"key":"10.1016\/j.jtos.2020.09.001_bib51","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1128\/AAC.47.1.48-53.2003","article-title":"Fourteen-member macrolides promote the phosphatidylserine receptor-dependent phagocytosis of apoptotic neutrophils by alveolar macrophages","volume":"47","author":"Yamaryo","year":"2003","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.jtos.2020.09.001_bib52","doi-asserted-by":"crossref","first-page":"781","DOI":"10.1097\/ICO.0b013e3181cda38f","article-title":"Topical azithromycin therapy for meibomian gland dysfunction: clinical response and lipid alterations","volume":"29","author":"Foulks","year":"2010","journal-title":"Cornea"},{"key":"10.1016\/j.jtos.2020.09.001_bib53","doi-asserted-by":"crossref","first-page":"1289","DOI":"10.1007\/s00417-019-04322-1","article-title":"Efficacy of azithromycin 1.5% eyedrops vs oral doxycycline in meibomian gland dysfunction: a randomized trial","volume":"257","author":"Satitpitakul","year":"2019","journal-title":"Graefe\u2019s Arch Clin Exp Ophthalmol"},{"key":"10.1016\/j.jtos.2020.09.001_bib54","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1136\/bjophthalmol-2014-305410","article-title":"Oral azithromycin versus doxycycline in meibomian gland dysfunction: a randomised double-masked open-label clinical trial","volume":"99","author":"Kashkouli","year":"2015","journal-title":"Br J Ophthalmol"},{"key":"10.1016\/j.jtos.2020.09.001_bib55","doi-asserted-by":"crossref","first-page":"1172","DOI":"10.1016\/j.ajo.2014.08.015","article-title":"Effects of topical loteprednol etabonate on tear cytokines and clinical outcomes in moderate and severe meibomian gland dysfunction: randomized clinical trial","volume":"158","author":"Lee","year":"2014","journal-title":"Am J Ophthalmol"},{"key":"10.1016\/j.jtos.2020.09.001_bib56","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1002\/(SICI)1098-1128(200001)20:1<58::AID-MED3>3.0.CO;2-X","article-title":"Soft drug design: general principles and recent applications","volume":"20","author":"Bodor","year":"2000","journal-title":"Med Res Rev"},{"key":"10.1016\/j.jtos.2020.09.001_bib57","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1016\/j.jtos.2017.05.006","article-title":"TFOS DEWS II management and therapy report","volume":"15","author":"Jones","year":"2017","journal-title":"Ocul Surf"},{"key":"10.1016\/j.jtos.2020.09.001_bib58","doi-asserted-by":"crossref","first-page":"1386\u20101393","DOI":"10.1097\/ICO.0b013e31823cc098","article-title":"A randomized double-masked study of 0.05% cyclosporine ophthalmic emulsion in the treatment of meibomian gland dysfunction","volume":"31","author":"Prabhasawat","year":"2012","journal-title":"Cornea"},{"key":"10.1016\/j.jtos.2020.09.001_bib59","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1093\/ajcn\/71.1.343S","article-title":"Dietary polyunsaturated fatty acids and inflammatory mediator production","volume":"71","author":"James","year":"2000","journal-title":"Am J Clin Nutr"},{"key":"10.1016\/j.jtos.2020.09.001_bib60","doi-asserted-by":"crossref","first-page":"887","DOI":"10.1093\/ajcn\/82.4.887","article-title":"Relation between dietary n-3 and n-6 fatty acids and clinically diagnosed dry eye syndrome in women","volume":"82","author":"Miljanovi\u0107","year":"2005","journal-title":"Am J Clin Nutr"},{"key":"10.1016\/j.jtos.2020.09.001_bib61","first-page":"1133\u20101138","article-title":"A randomized, double-masked study to evaluate the effect of omega-3 fatty acids supplementation in meibomian gland dysfunction","volume":"8","author":"Ole\u00f1ik","year":"2013","journal-title":"Clin Interv Aging"},{"key":"10.1016\/j.jtos.2020.09.001_bib62","doi-asserted-by":"crossref","first-page":"1185\u20101191","DOI":"10.1097\/ICO.0000000000000940","article-title":"Effect of oral Re-esterified omega-3 nutritional supplementation on dry eyes","volume":"35","author":"Epitropoulos","year":"2016","journal-title":"Cornea"},{"key":"10.1016\/j.jtos.2020.09.001_bib63","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1097\/ICO.0000000000000366","article-title":"Effect of using a combination of lid wipes, eye drops, and omega-3 supplements on meibomian gland functionality in patients with lipid deficient\/evaporative dry eye","volume":"34","author":"Korb","year":"2015","journal-title":"Cornea"},{"key":"10.1016\/j.jtos.2020.09.001_bib64","doi-asserted-by":"crossref","first-page":"2601","DOI":"10.1167\/iovs.11-9228","article-title":"Prevalence of asymp-tomatic and symptomatic meibomian gland dysfunction in the general population of Spain","volume":"53","author":"Viso","year":"2012","journal-title":"IOVS (Investig Ophthalmol Vis Sci)"},{"key":"10.1016\/j.jtos.2020.09.001_bib65","doi-asserted-by":"crossref","first-page":"1274\u20101280","DOI":"10.3109\/02713683.2015.1122810","article-title":"A randomized controlled trial of omega 3 fatty acids in rosacea patients with dry eye symptoms","volume":"41","author":"Bhargava","year":"2016","journal-title":"Curr Eye Res"},{"key":"10.1016\/j.jtos.2020.09.001_bib66","doi-asserted-by":"crossref","first-page":"515\u2010521","DOI":"10.1007\/s10384-014-0342-4","article-title":"Expression of the P2Y\u2082 receptor on the rat ocular surface during a 1-year rearing period","volume":"58","author":"Tanioka","year":"2014","journal-title":"Jpn J Ophthalmol"},{"key":"10.1016\/j.jtos.2020.09.001_bib67","doi-asserted-by":"crossref","first-page":"9091","DOI":"10.1038\/s41598-019-45475-7","article-title":"Tear film lipid layer increase after diquafosol instillation in dry eye patients with meibomian gland dysfunction: a randomized clinical study","volume":"9","author":"Fukuoka","year":"2019","journal-title":"Sci Rep"},{"key":"10.1016\/j.jtos.2020.09.001_bib68","doi-asserted-by":"crossref","first-page":"1145","DOI":"10.1097\/ICO.0b013e3181d836f3","article-title":"Intraductal meibomian gland probing relieves symptoms of obstructive meibomian gland dysfunction","volume":"29","author":"Maskin","year":"2010","journal-title":"Cornea"},{"key":"10.1016\/j.jtos.2020.09.001_bib69","doi-asserted-by":"crossref","first-page":"725","DOI":"10.1097\/ICO.0000000000000777","article-title":"Efficacy of intraductal meibomian gland probing on tear function in patients with obstructive meibomian gland dysfunction","volume":"35","author":"Ma","year":"2016","journal-title":"Cornea"},{"key":"10.1016\/j.jtos.2020.09.001_bib70","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12886-019-1219-6","article-title":"Clinical results of Intraductal Meibomian gland probing combined with intense pulsed light in treating patients with refractory obstructive Meibomian gland dysfunction: a randomized controlled trial","volume":"19","author":"Huang","year":"2019","journal-title":"BMC Ophthalmol"},{"key":"10.1016\/j.jtos.2020.09.001_bib71","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1097\/OPX.0b013e318181adef","article-title":"Inner eyelid surface temperature as a function of warm compress methodology","volume":"85","author":"Blackie","year":"2008","journal-title":"Optom Vis Sci"},{"key":"10.1016\/j.jtos.2020.09.001_bib72","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1007\/s40123-014-0025-8","article-title":"A randomized, controlled treatment trial of eyelid-warming therapies in meibomian gland dysfunction","volume":"3","author":"Sim","year":"2014","journal-title":"Ophthalmol Ther"},{"key":"10.1016\/j.jtos.2020.09.001_bib73","doi-asserted-by":"crossref","first-page":"1707\u20101711","DOI":"10.1136\/bjophthalmol-2014-305220","article-title":"Randomised masked clinical trial of the MGDRx EyeBag for the treatment of meibomian gland dysfunction-related evaporative dry eye","volume":"98","author":"Bilkhu","year":"2014","journal-title":"Br J Ophthalmol"},{"key":"10.1016\/j.jtos.2020.09.001_bib74","doi-asserted-by":"crossref","first-page":"146\u2010154","DOI":"10.1016\/j.jtos.2013.12.001","article-title":"Evaluation of an automated thermodynamic treatment (LipiFlow) system for meibomian gland dysfunction: a prospective, randomized, observer-masked trial","volume":"12","author":"Finis","year":"2014","journal-title":"Ocul Surf"},{"key":"10.1016\/j.jtos.2020.09.001_bib75","doi-asserted-by":"crossref","first-page":"1385\u20101396","DOI":"10.2147\/OPTH.S109663","article-title":"The sustained effect (12 months) of a single-dose vectored thermal pulsation procedure for meibomian gland dysfunction and evaporative dry eye","volume":"10","author":"Blackie","year":"2016","journal-title":"Clin Ophthalmol"},{"key":"10.1016\/j.jtos.2020.09.001_bib76","doi-asserted-by":"crossref","first-page":"161\u2010168","DOI":"10.2147\/OPTH.S150433","article-title":"Comparison of a single-dose vectored thermal pulsation procedure with a 3-month course of daily oral doxycycline for moderate-to-severe meibomian gland dysfunction","volume":"12","author":"Hagen","year":"2018","journal-title":"Clin Ophthalmol"},{"key":"10.1016\/j.jtos.2020.09.001_bib77","doi-asserted-by":"crossref","first-page":"403\u2010407","DOI":"10.1097\/ICO.0000000000002235","article-title":"A 6-week, prospective, randomized, single-masked study of lifitegrast ophthalmic solution 5% versus thermal pulsation procedure for treatment of inflammatory meibomian gland dysfunction","volume":"39","author":"Tauber","year":"2020","journal-title":"Cornea"},{"key":"10.1016\/j.jtos.2020.09.001_bib78","doi-asserted-by":"crossref","DOI":"10.1155\/2014\/618206","article-title":"Unconventional use of intense pulsed light","volume":"2014","author":"Piccolo","year":"2014","journal-title":"BioMed Res Int"},{"key":"10.1016\/j.jtos.2020.09.001_bib79","doi-asserted-by":"crossref","first-page":"1285","DOI":"10.1097\/00042728-200510000-00004","article-title":"Effective treatment of rosacea using intense pulsed light systems","volume":"31","author":"Schroeter","year":"2005","journal-title":"Dermatol Surg"},{"key":"10.1016\/j.jtos.2020.09.001_bib80","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1089\/pho.2014.3819","article-title":"Intense pulsed light treatment for dry eye disease due to meibomian gland dysfunction; a 3-year retrospective study","volume":"33","author":"Toyos","year":"2015","journal-title":"Photomed Laser Surg"},{"key":"10.1016\/j.jtos.2020.09.001_bib81","doi-asserted-by":"crossref","first-page":"1494","DOI":"10.1111\/j.1365-2672.2009.04545.x","article-title":"Investigation of critical inter-related factors affecting the efficacy of pulsed light for inactivating clinically relevant bacterial pathogens","volume":"108","author":"Farrell","year":"2010","journal-title":"J Appl Microbiol"},{"key":"10.1016\/j.jtos.2020.09.001_bib82","doi-asserted-by":"crossref","first-page":"1965\u20101970","DOI":"10.1167\/iovs.14-15764","article-title":"Prospective trial of intense pulsed light for the treatment of meibomian gland dysfunction","volume":"56","author":"Craig","year":"2015","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"10.1016\/j.jtos.2020.09.001_bib83","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/j.ajo.2017.08.021","article-title":"Analysis of cytokine levels in tears and clinical correlations after intense pulsed light treating meibomian gland dysfunction","volume":"183","author":"Liu","year":"2017","journal-title":"Am J Ophthalmol"},{"key":"10.1016\/j.jtos.2020.09.001_bib84","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1089\/pho.2017.4402","article-title":"Intense pulsed light applied directly on eyelids combined with meibomian gland expression to treat meibomian gland dysfunction","volume":"36","author":"Rong","year":"2018","journal-title":"Photomed Laser Surg"},{"key":"10.1016\/j.jtos.2020.09.001_bib85","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1016\/j.jtos.2018.11.004","article-title":"Therapeutic efficacy of intense pulsed light in patients with refractory meibomian gland dysfunction","volume":"17","author":"Arita","year":"2019","journal-title":"Ocul Surf"},{"key":"10.1016\/j.jtos.2020.09.001_bib86","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1097\/ICO.0000000000002204","article-title":"Efficacy and safety of intense pulsed light in patients with meibomian gland dysfunction-A randomized, double-masked, sham-controlled clinical trial","volume":"39","author":"Piyacomn","year":"2020","journal-title":"Cornea"},{"key":"10.1016\/j.jtos.2020.09.001_bib87","doi-asserted-by":"crossref","first-page":"286\u2010297","DOI":"10.1016\/j.jtos.2020.01.003","article-title":"Randomised double-masked placebo-controlled trial of the cumulative treatment efficacy profile of intense pulsed light therapy for meibomian gland dysfunction","volume":"18","author":"Xue","year":"2020","journal-title":"Ocul Surf"},{"key":"10.1016\/j.jtos.2020.09.001_bib88","doi-asserted-by":"crossref","DOI":"10.1007\/s10792-020-01337-0","article-title":"Comparison of two intense pulsed light patterns for treating patients with meibomian gland dysfunction","author":"Wu","year":"2020","journal-title":"Int Ophthalmol"},{"key":"10.1016\/j.jtos.2020.09.001_bib89","doi-asserted-by":"crossref","first-page":"814\u2010819","DOI":"10.1136\/bjophthalmol-2016-308678","article-title":"Transcutaneous periorbital electrical stimulation in the treatment of dry eye","volume":"101","author":"Pedrotti","year":"2017","journal-title":"Br J Ophthalmol"},{"key":"10.1016\/j.jtos.2020.09.001_bib90","doi-asserted-by":"crossref","first-page":"1313\u20101322","DOI":"10.1111\/iwj.12805","article-title":"Quantum molecular resonance technology in hard-to-heal extremity wounds: histological and clinical results","volume":"14","author":"Fraccalvieri","year":"2017","journal-title":"Int Wound J"},{"key":"10.1016\/j.jtos.2020.09.001_bib91","doi-asserted-by":"crossref","first-page":"1424\u20101429","DOI":"10.1097\/ICO.0000000000002063","article-title":"High frequency electrotherapy for the treatment of meibomian gland dysfunction","volume":"38","author":"Ferrari","year":"2019","journal-title":"Cornea"}],"container-title":["The Ocular Surface"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1542012420301415?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1542012420301415?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,27]],"date-time":"2025-10-27T04:41:20Z","timestamp":1761540080000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1542012420301415"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,10]]},"references-count":91,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2020,10]]}},"alternative-id":["S1542012420301415"],"URL":"https:\/\/doi.org\/10.1016\/j.jtos.2020.09.001","relation":{},"ISSN":["1542-0124"],"issn-type":[{"value":"1542-0124","type":"print"}],"subject":[],"published":{"date-parts":[[2020,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Latest evidences on meibomian gland dysfunction diagnosis and management","name":"articletitle","label":"Article Title"},{"value":"The Ocular Surface","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jtos.2020.09.001","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}